Home
Account
Research Tools & Data
Educate
Contribute
News
ETFs
Sectors
About
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Economic Calendar
Chart School
Tutorials
Learning Center
Submit Article
Join Blog Network
Chat Rooms
Rate Broker
Rate Software
About Us
Contact Us
Advertise With Us
Terms and Conditions
Enter Symbol
Overview
Community Research
Stock Sentiment
Whisper Estimates
Enter Estimates
Company Profile
Technical Charts
Competitors
Analyst Ratings
Analyst Estimates
Sales Estimates
Related News
Blog Articles
Press Releases
Message Board
Option Chain
Financial Ratios
Technicals
SEC Filings
Sector: Medical
AVI BioPharma, Inc. (NASDAQ: AVII)
3m
6m
1y
2y
Ranking History
This Week
Last Week
Two Weeks Back
Three Weeks Back
Please login to view our current ranking data
Click here to login
No Information
No Information
No Information
Disclaimer
Headlines
Blog Articles
Premium News
Press Releases
SEC
AVI BioPharma, Inc. Presents Update on AVI-4658 at TREAT-NMD / NIH International Conference
Nov 19, 2009 08:01 AM |
AVII
AVI BioPharma, Inc. to Present at Transformational Medical Technologies Initiative (TMTI) Industry Day
Nov 18, 2009 08:02 AM |
AVII
AVI BioPharma Announces Third Quarter 2009 Financial Results & Corporate Highlights
Nov 09, 2009 08:01 AM |
AVII
AVI BioPharma Announces Third Quarter 2009 Financial Results Conference Call
Nov 02, 2009 08:01 AM |
AVII
AVI BioPharma Presents Updated Safety Data From Ongoing Systemic Trial of AVI-4658 at 7th Annual Action Duchenne International Conference
Oct 26, 2009 08:01 AM |
AVII
Exon Skipping Drug Prevents Muscle Wasting and Maintains Muscle Function in Severely Affected, Dystrophin Deficient Mice
Oct 20, 2009 10:00 AM |
AVII
Exon Skipping Therapy Shows Promise in Prevention or Delay of Heart Disease Associated With Duchenne Muscular Dystrophy
Oct 19, 2009 08:01 AM |
AVII
Small-Cap Biotech Stocks To Keep An Eye On
Oct 05, 2009 09:37 AM |
AVII
,
CVM
,
HGSI
,
INO
,
ONCY
Pre-Market: Stocks Called Higher At Open - Financials Among Standout Gainers After Analyst Note
Oct 05, 2009 09:20 AM |
AVII
,
BAC
,
BRCD
,
CMA
,
COF
,
HPQ
AVI BioPharma Receives Expanded Contract From U.S. Department of Defense to Develop Its Drug Candidate for the Treatment of Junin Virus Infection
Oct 05, 2009 08:01 AM |
AVII
More..
AIG, UBS, GameStop, Barnes & Noble are big movers
Aug 20, 2009 05:14 PM |
AIG
,
AVII
,
BKS
,
DKS
,
GME
AVI BioPharma Q4 Revenues Up
Mar 10, 2009 08:25 AM |
AVII
More..
AVI BioPharma, Inc. to Present Leading PPMO Drug Delivery Technology at Upcoming Scientific Meetings
Aug 27, 2009 08:03 AM |
AVII
AVI BioPharma Phase 1 Proof of Concept and Safety Data for AVI-4658 in Duchenne Muscular Dystrophy Featured in Lancet Neurology
Aug 25, 2009 08:13 PM |
AVII
AVI BioPharma to Present Safety Data in Duchenne Muscular Dystrophy at 14th Annual International Congress of the World Muscle Society
Aug 25, 2009 08:12 PM |
AVII
AVI BioPharma Announces Closing of Public Offering of Common Stock and Warrants
Aug 25, 2009 09:52 AM |
AVII
AVI BioPharma Announces Pricing of Public Offering of Common Stock and Warrants
Aug 20, 2009 06:01 AM |
AVII
AVI BioPharma, Inc. Announces Proposed Public Offering of Common Stock and Warrants
Aug 19, 2009 04:46 PM |
AVII
BenchmarkJournal.Com Free Analyst Review for BARE, IACI, AVII, ICON, SLAB and CRBC
Aug 10, 2009 10:17 AM |
AVII
,
BARE
,
CRBC
,
IACI
,
ICON
,
SLAB
AVI BioPharma Announces Second Quarter 2009 Financial Results & Corporate Highlights
Aug 10, 2009 08:01 AM |
AVII
BioMed Realty Trust Commemorates Five-Year Anniversary As a Public Company ; Ringing NYSE Closing Bell(R) Today; Provides Tenant Update
Aug 06, 2009 06:53 AM |
ARNA
,
AVII
,
AZN
,
BMR
,
CEPH
,
EPCT
BioMed Realty Trust Commemorates Five-Year Anniversary as a Public Company
Aug 06, 2009 06:01 AM |
AVII
,
BMR
More..
Form 4 AVI BIOPHARMA INC For: Nov 10 Filed by: EASTBOURNE CAPITAL MANAGEMENT LLC/CA (10K)
Nov 13, 2009 05:55 PM
Form 4/A AVI BIOPHARMA INC For: May 19 Filed by: Price Ben Gil (10K)
Oct 19, 2009 11:17 PM
Form 4/A AVI BIOPHARMA INC For: May 19 Filed by: HODGMAN JOHN (10K)
Oct 19, 2009 11:17 PM
Form 4/A AVI BIOPHARMA INC For: May 19 Filed by: Goolsbee William Alden (10K)
Oct 19, 2009 11:17 PM
Form 4/A AVI BIOPHARMA INC For: May 19 Filed by: FORREST K MICHAEL (10K)
Oct 19, 2009 11:16 PM
Form 4/A AVI BIOPHARMA INC For: May 19 Filed by: CASEY MICHAEL D (10K)
Oct 19, 2009 11:16 PM
Form 4 HAYWOOD GEORGE WEAVER For: Aug 21 (10K)
Aug 25, 2009 04:38 PM
Form 3 BLACK BEAR OFFSHORE MAST For: May 31 (10K)
Jun 02, 2009 02:28 PM
Form 3 AVI BIOPHARMA INC For: May 31 Filed by: EASTBOURNE CAPITAL MANAGEMENT LLC/CA (10K)
Jun 02, 2009 12:56 PM
Form 4 Goolsbee William Alden For: May 19 (10K)
May 21, 2009 11:26 PM
More..
Analyst Ratings
More Details
Sentiment Survey
Avg. Short Term
Avg. Long Term
Avg. Grade
More Details
Share Performance
Period
AVII
Compare to S&P
YTD
121.89 %
83.64 %
4 Weeks
-14.62 %
-15.54 %
12 Weeks
0.69 %
-5.07 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
-33.33 %
EPS Growth in Last Year:
0.00 %
Sales Growth in Last Quarter:
115.59 %
Sales Growth in Last Quarter:
22.78 %
More...
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##
Fundamental data is provided by
Zacks Investment Research
, market data is provided by
AlphaTrade.
, and Commentary and Press Releases provided by
Quotemedia
